BioSpace News Archive

Genetown

Charles River Laboratories Announces Offering of $500 Million of Senior Notes

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it intends to offer $500 million in aggregate principal amount of senior notes due 2028 (the “notes”) in an unregistered offering, subject to market conditions.

October 21, 2019
·
3 min read
Hemostemix Announces Positive Results and Conclusions Reported in Phase II CLI Trial Abstract

Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB: HMTXF), a biotechnology company developing and commercializing blood-derived stem cell therapies for unmet medical conditions, is pleased to provide a summary of the presentation entitled “Autologous Stem Cell Treatment for CLI Patients with No Revascularization Options: An Update of the Hemostemix ACP-01 Trial With 4.5 Year Followup.”

October 21, 2019
·
5 min read
Drug Development

Myovant Sciences Completes Patient Recruitment for Phase 3 SPIRIT 1 Study Evaluating Relugolix Combination Therapy in Women with Endometriosis

Top-line results for SPIRIT 2 and SPIRIT 1 expected in the first and second quarters of 2020, respectively Studies support potential regulatory submission for a single tablet, once-daily treatment of moderate-to-severe endometriosis-associated pain

October 21, 2019
·
7 min read
Deals

Spherix Issues Update to Shareholders - Oct. 21, 2019

Spherix Incorporated President and CEO, Anthony Hayes, released a letter to shareholders outlining the Company’s plans for its previously disclosed dividend distribution.

October 21, 2019
·
5 min read
Pharm Country

LyGenesis Closes $4 Million Convertible Debt Financing to Begin Clinical Development of its Liver Regeneration Technology

Funds will support a Phase 2a clinical trial for patients with end stage liver disease in 2020

October 21, 2019
·
3 min read
Business

Harvard Bioscience Announces Executive Appointment

Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that Ken Olson has been named Vice President and General Manager, Pre-Clinical Systems (DSI), reporting to Chairman, President and CEO, Jim Green.

October 21, 2019
·
1 min read
Propanc Biopharma Illustrates Novel Mode of Action of PRP, Suppressing EMT Pathways and Metastasis in Cancer Patients

PRP a Potential Method for Reducing Recurrence After Drug Treatment Failures Global Metastatic Cancer Treatment Market Anticipated to Reach $98.24 Billion By 2025

October 21, 2019
·
7 min read
Genetown

Halloran Consulting Group Launches Speaker Series to Drive Meaningful Discussions and Share Insights on Medical Advancements in the Life Science Industry

Halloran Consulting Group, a life science regulatory, quality and clinical consulting firm, announced the launch of its Speaker Series, an interactive speaking circuit featuring Halloran’s most experienced strategic thinkers.

October 21, 2019
·
4 min read
Business

BlackThorn Therapeutics Appoints William J. Martin, Ph.D., as Chief Executive Officer to Lead Next Stage of Growth

Dr. Martin has previously served as the company’s president and chief operating officer, as well as its chief scientific officer.

October 21, 2019
·
5 min read
Business

Jane Sullivan Joins Golden Leaf Holdings as Chief People Officer

Golden Leaf Holdings, (CSE: GLH) (OTCQB: GLDFF) (“Golden Leaf” or the “Company”), a pioneering cannabis company with cultivation, production and retail built around recognized brands, announced the appointment of Jane Sullivan to the newly created role of Chief People Officer

October 21, 2019
·
5 min read